Cargando…

Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer

Palliative treatment concepts are considered in patients with non-curatively resectable and/or metastasized pancreatic cancer. However, patients without metastases, but presented with marginally resectable or locally non-resectable tumors should not be treated by a palliative therapeutic approach. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Assfalg, Volker, Hüser, Norbert, Michalski, Christoph, Gillen, Sonja, Kleeff, Jorg, Friess, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756382/
https://www.ncbi.nlm.nih.gov/pubmed/24212634
http://dx.doi.org/10.3390/cancers3010652
_version_ 1782282085982011392
author Assfalg, Volker
Hüser, Norbert
Michalski, Christoph
Gillen, Sonja
Kleeff, Jorg
Friess, Helmut
author_facet Assfalg, Volker
Hüser, Norbert
Michalski, Christoph
Gillen, Sonja
Kleeff, Jorg
Friess, Helmut
author_sort Assfalg, Volker
collection PubMed
description Palliative treatment concepts are considered in patients with non-curatively resectable and/or metastasized pancreatic cancer. However, patients without metastases, but presented with marginally resectable or locally non-resectable tumors should not be treated by a palliative therapeutic approach. These patients should be enrolled in neoadjuvant radiochemotherapy trials because a potentially curative resection can be achieved in approximately one-third of them after finishing treatment and restaging. Within the scope of best possible palliative care, resection of the primary cancer together with excision of metastases represents a therapeutic option to be contemplated in selected cases. Comprehensive palliative therapy is based on treatment of bile duct or duodenal obstruction for certain locally unresectable or metastasized advanced pancreatic cancer. However, endoscopic or percutaneous stenting procedures and surgical bypass provide safe and highly effective therapeutic alternatives. In case of operative drainage of the biliary tract (biliodigestive anastomosis), the prophylactic creation of a gastro-intestinal bypass (double bypass) is recommended. The decision to perform a surgical versus an endoscopic procedure for palliation depends to a great extent on the tumor stage and the estimated prognosis, and should be determined by an interdisciplinary team for each patient individually.
format Online
Article
Text
id pubmed-3756382
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-37563822013-09-04 Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer Assfalg, Volker Hüser, Norbert Michalski, Christoph Gillen, Sonja Kleeff, Jorg Friess, Helmut Cancers (Basel) Review Palliative treatment concepts are considered in patients with non-curatively resectable and/or metastasized pancreatic cancer. However, patients without metastases, but presented with marginally resectable or locally non-resectable tumors should not be treated by a palliative therapeutic approach. These patients should be enrolled in neoadjuvant radiochemotherapy trials because a potentially curative resection can be achieved in approximately one-third of them after finishing treatment and restaging. Within the scope of best possible palliative care, resection of the primary cancer together with excision of metastases represents a therapeutic option to be contemplated in selected cases. Comprehensive palliative therapy is based on treatment of bile duct or duodenal obstruction for certain locally unresectable or metastasized advanced pancreatic cancer. However, endoscopic or percutaneous stenting procedures and surgical bypass provide safe and highly effective therapeutic alternatives. In case of operative drainage of the biliary tract (biliodigestive anastomosis), the prophylactic creation of a gastro-intestinal bypass (double bypass) is recommended. The decision to perform a surgical versus an endoscopic procedure for palliation depends to a great extent on the tumor stage and the estimated prognosis, and should be determined by an interdisciplinary team for each patient individually. Molecular Diversity Preservation International (MDPI) 2011-02-14 /pmc/articles/PMC3756382/ /pubmed/24212634 http://dx.doi.org/10.3390/cancers3010652 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Assfalg, Volker
Hüser, Norbert
Michalski, Christoph
Gillen, Sonja
Kleeff, Jorg
Friess, Helmut
Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
title Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
title_full Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
title_fullStr Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
title_full_unstemmed Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
title_short Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
title_sort palliative interventional and surgical therapy for unresectable pancreatic cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756382/
https://www.ncbi.nlm.nih.gov/pubmed/24212634
http://dx.doi.org/10.3390/cancers3010652
work_keys_str_mv AT assfalgvolker palliativeinterventionalandsurgicaltherapyforunresectablepancreaticcancer
AT husernorbert palliativeinterventionalandsurgicaltherapyforunresectablepancreaticcancer
AT michalskichristoph palliativeinterventionalandsurgicaltherapyforunresectablepancreaticcancer
AT gillensonja palliativeinterventionalandsurgicaltherapyforunresectablepancreaticcancer
AT kleeffjorg palliativeinterventionalandsurgicaltherapyforunresectablepancreaticcancer
AT friesshelmut palliativeinterventionalandsurgicaltherapyforunresectablepancreaticcancer